110 related articles for article (PubMed ID: 11689076)
1. A novel series of 2,6,7-substituted 2,3-dihydro-1,4-benzodioxin and 2,6,7-substituted 1,4-benzodioxin derivatives as lipid peroxidation inhibitors. Structure-activity relationships for high inhibition of human low-density lipoprotein peroxidation.
Thiéry V; Coudert G; Bizot-Espiard JG; Pfeiffer B; Renard P; Lindenbaum A; Guillaumet G
J Med Chem; 2001 Nov; 44(23):3904-14. PubMed ID: 11689076
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide releasing morpholine derivatives as hypolipidemic and antioxidant agents.
Chrysselis MC; Rekka EA; Siskou IC; Kourounakis PN
J Med Chem; 2002 Nov; 45(24):5406-9. PubMed ID: 12431068
[TBL] [Abstract][Full Text] [Related]
3. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
Chrysselis MC; Rekka EA; Kourounakis PN
J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
[TBL] [Abstract][Full Text] [Related]
4. Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity.
Annoura H; Nakanishi K; Toba T; Takemoto N; Imajo S; Miyajima A; Tamura-Horikawa Y; Tamura S
J Med Chem; 2000 Sep; 43(18):3372-6. PubMed ID: 10978184
[No Abstract] [Full Text] [Related]
5. Design and synthesis of substituted compounds containing the 1, 4-benzodioxin subunit. New potential calcium antagonists.
Sánchez I; Dolors Pujol M; Guillaumet G; Massingham R; Monteil A; Dureng G; Winslow E
Eur J Med Chem; 2000; 35(7-8):663-76. PubMed ID: 10960182
[TBL] [Abstract][Full Text] [Related]
6. Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.
Vázquez M; Merlos M; Adzet T; Laguna JC
Br J Pharmacol; 1996 Mar; 117(6):1155-62. PubMed ID: 8882610
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate.
Hayashi K; Kuga Y; Nomura S; Okura Y; Tanaka K; Yasunobu Y; Nomura K; Shingu T; Kuwashima J; Kajiyama G
Arzneimittelforschung; 1996 Apr; 46(4):378-81. PubMed ID: 8740082
[TBL] [Abstract][Full Text] [Related]
8. Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3, 5-di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones.
Kato T; Ozaki T; Tamura K; Suzuki Y; Akima M; Ohi N
J Med Chem; 1998 Oct; 41(22):4309-16. PubMed ID: 9784106
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 3',5'-di-tert-butyl-4'-hydroxyflavones as potential inhibitors of low density lipoprotein (LDL) oxidation.
Lewin G; Rolland Y; Privat S; Breugnot C; Lenaers A; Vilaine JP; Baltaze JP; Poisson J
J Nat Prod; 1995 Dec; 58(12):1840-7. PubMed ID: 8691205
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of multi-substituted benzylidenethiazolidine-2,4-diones on LDL oxidation.
Jeong TS; Kim JR; Kim KS; Cho KH; Bae KH; Lee WS
Bioorg Med Chem; 2004 Aug; 12(15):4017-23. PubMed ID: 15246079
[TBL] [Abstract][Full Text] [Related]
11. Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities.
Kimura M; Masuda T; Yamada K; Kubota N; Kawakatsu N; Mitani M; Kishii K; Inazu M; Namiki T
Bioorg Med Chem Lett; 2002 Aug; 12(15):1947-50. PubMed ID: 12113815
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and Hypolipidemic Effect of Novel Conjugates with Trolox and Other Antioxidant Acids.
Theodosis-Nobelos P; Kourounakis PN; Rekka EA
Med Chem; 2017; 13(3):214-225. PubMed ID: 27823562
[TBL] [Abstract][Full Text] [Related]
13. 1,3-Benzodioxole-based fibrate derivatives as potential hypolipidemic and hepatoprotective agents.
Xie YD; Xu YH; Liu JP; Wang B; Shi YH; Wang W; Wang XP; Sun M; Xu XY; Bian XL
Bioorg Med Chem Lett; 2021 Jul; 43():127898. PubMed ID: 33684440
[TBL] [Abstract][Full Text] [Related]
14. Novel indole-2-carboxamide and cycloalkeno[1,2-b]indole derivatives. Structure-activity relationships for high inhibition of human LDL peroxidation.
Kuehm-Caubere C; Caubere P; Jamart-Gregoire B; Negre-Salvayre A; Bonnefont-Rousselot D; Bizot-Espiard JG; Pfeiffer B; Caignard DH; Guardiola-Lemaitre B; Renard P
J Med Chem; 1997 Apr; 40(8):1201-10. PubMed ID: 9111294
[TBL] [Abstract][Full Text] [Related]
15. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
Tooulia KK; Theodosis-Nobelos P; Rekka EA
Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
[TBL] [Abstract][Full Text] [Related]
16. Anti-lipid-peroxidative principles from Tournefortia sarmentosa.
Lin YL; Chang YY; Kuo YH; Shiao MS
J Nat Prod; 2002 May; 65(5):745-7. PubMed ID: 12027757
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
Sashidhara KV; Dodda RP; Sonkar R; Palnati GR; Bhatia G
Eur J Med Chem; 2014 Jun; 81():499-509. PubMed ID: 24871900
[TBL] [Abstract][Full Text] [Related]
18. Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 2. Structure-activity relationships of thiazolidinone derivatives.
Kato T; Ozaki T; Tamura K; Suzuki Y; Akima M; Ohi N
J Med Chem; 1999 Aug; 42(16):3134-46. PubMed ID: 10447958
[TBL] [Abstract][Full Text] [Related]
19. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents.
Sashidhara KV; Palnati GR; Dodda RP; Sonkar R; Khanna AK; Bhatia G
Eur J Med Chem; 2012 Nov; 57():302-10. PubMed ID: 23078966
[TBL] [Abstract][Full Text] [Related]
20. Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents.
Yu MJ; McCowan JR; Thrasher KJ; Keith PT; Luttman CA; Ho PP; Towner RD; Bertsch B; Horng JS; Um SL
J Med Chem; 1992 Feb; 35(4):716-24. PubMed ID: 1542098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
